MA47495A - ANTI-INFLAMMATORY COMPOSITIONS INCLUDING IRAQ AND JAK INHIBITORS - Google Patents
ANTI-INFLAMMATORY COMPOSITIONS INCLUDING IRAQ AND JAK INHIBITORSInfo
- Publication number
- MA47495A MA47495A MA047495A MA47495A MA47495A MA 47495 A MA47495 A MA 47495A MA 047495 A MA047495 A MA 047495A MA 47495 A MA47495 A MA 47495A MA 47495 A MA47495 A MA 47495A
- Authority
- MA
- Morocco
- Prior art keywords
- iraq
- compositions including
- jak inhibitors
- inflammatory compositions
- inflammatory
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/444—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring heteroatom, e.g. amrinone
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/541—Non-condensed thiazines containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Pulmonology (AREA)
- Transplantation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB1702603.0A GB201702603D0 (en) | 2017-02-17 | 2017-02-17 | Novel compositions and pharmaceutical compositions thereof for the treatment of inflammatory disorders |
Publications (1)
Publication Number | Publication Date |
---|---|
MA47495A true MA47495A (en) | 2019-12-25 |
Family
ID=58486866
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MA047495A MA47495A (en) | 2017-02-17 | 2018-02-15 | ANTI-INFLAMMATORY COMPOSITIONS INCLUDING IRAQ AND JAK INHIBITORS |
Country Status (13)
Country | Link |
---|---|
EP (1) | EP3582775A1 (en) |
JP (1) | JP2020507612A (en) |
KR (1) | KR20190117672A (en) |
CN (1) | CN110300586A (en) |
AU (1) | AU2018221761A1 (en) |
BR (1) | BR112019016949A2 (en) |
CA (1) | CA3054652A1 (en) |
GB (1) | GB201702603D0 (en) |
MA (1) | MA47495A (en) |
MX (1) | MX2019009658A (en) |
PH (1) | PH12019501853A1 (en) |
SG (1) | SG11201907492TA (en) |
WO (1) | WO2018149925A1 (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2019111218A1 (en) | 2017-12-08 | 2019-06-13 | Cadila Healthcare Limited | Novel heterocyclic compounds as irak4 inhibitors |
CN113713083A (en) * | 2020-05-25 | 2021-11-30 | 南京帝昌医药科技有限公司 | Pharmaceutical composition for treating alopecia |
CN115843296B (en) | 2020-08-07 | 2024-03-08 | 南京迈晟科技有限责任公司 | CDK9 inhibitors and uses thereof |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JO3041B1 (en) | 2008-07-25 | 2016-09-05 | Galapagos Nv | Novel compounds useful for the treatment of degenerative and inflammatory diseases |
TWI462920B (en) | 2009-06-26 | 2014-12-01 | 葛萊伯格有限公司 | Novel compound useful for the treatment of degenerative and inflammatory diseases |
MX368511B (en) | 2012-06-22 | 2019-10-07 | Galapagos Nv | Aminotriazolopyridine for use in the treatment of inflammation, and pharmaceutical compositions thereof. |
GB201402071D0 (en) | 2014-02-07 | 2014-03-26 | Galapagos Nv | Novel salts and pharmaceutical compositions thereof for the treatment of inflammatory disorders |
GB201402070D0 (en) | 2014-02-07 | 2014-03-26 | Galapagos Nv | Pharmaceutical compositions for the treatment of inflammatory disorders |
GB201518456D0 (en) * | 2015-10-19 | 2015-12-02 | Galapagos Nv | Novel compounds and pharmaceutical compositions thereof for the treatment of inflammatory, autoimmune and/or proliferative diseases |
WO2017106564A1 (en) * | 2015-12-17 | 2017-06-22 | Gilead Sciences, Inc. | Combination of a jak inhibitor and a syk inhibitor for treating cancers and inflammatory disorders |
-
2017
- 2017-02-17 GB GBGB1702603.0A patent/GB201702603D0/en not_active Ceased
-
2018
- 2018-02-15 MA MA047495A patent/MA47495A/en unknown
- 2018-02-15 BR BR112019016949-0A patent/BR112019016949A2/en not_active Application Discontinuation
- 2018-02-15 WO PCT/EP2018/053803 patent/WO2018149925A1/en unknown
- 2018-02-15 AU AU2018221761A patent/AU2018221761A1/en not_active Abandoned
- 2018-02-15 CN CN201880012183.5A patent/CN110300586A/en active Pending
- 2018-02-15 CA CA3054652A patent/CA3054652A1/en not_active Abandoned
- 2018-02-15 MX MX2019009658A patent/MX2019009658A/en unknown
- 2018-02-15 EP EP18707866.2A patent/EP3582775A1/en not_active Withdrawn
- 2018-02-15 SG SG11201907492TA patent/SG11201907492TA/en unknown
- 2018-02-15 JP JP2019544638A patent/JP2020507612A/en active Pending
- 2018-02-15 KR KR1020197027092A patent/KR20190117672A/en unknown
-
2019
- 2019-08-08 PH PH12019501853A patent/PH12019501853A1/en unknown
Also Published As
Publication number | Publication date |
---|---|
BR112019016949A2 (en) | 2020-05-26 |
JP2020507612A (en) | 2020-03-12 |
MX2019009658A (en) | 2019-10-02 |
CA3054652A1 (en) | 2018-08-23 |
CN110300586A (en) | 2019-10-01 |
GB201702603D0 (en) | 2017-04-05 |
WO2018149925A1 (en) | 2018-08-23 |
PH12019501853A1 (en) | 2020-06-15 |
KR20190117672A (en) | 2019-10-16 |
AU2018221761A1 (en) | 2019-10-03 |
EP3582775A1 (en) | 2019-12-25 |
SG11201907492TA (en) | 2019-09-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK3565550T3 (en) | PHARMACEUTICAL COMPOSITIONS INCLUDING MELOXICAM AND RIZATRIPTANE | |
MA46427A (en) | COMPOSITIONS OF OLIGONUCLEOTIDES AND RELATED PROCESSES | |
MA44991A (en) | POLYTHERAPIES OF HDAC INHIBITORS AND PD-1 INHIBITORS | |
MA44990A (en) | POLYTHERAPIES OF HDAC INHIBITORS AND PD-L1 INHIBITORS | |
DK3600364T3 (en) | COMPOSITIONS INCLUDING A BACTERIA TRACT OF THE GENEAL MEGASPHAERA GENERAL AND USES THEREOF | |
MA45270A (en) | COMPOSITIONS OF OLIGONUCLEOTIDES AND RELATED PROCESSES | |
DK3890488T3 (en) | HERBICIDE COMPOSITIONS | |
MA52004A (en) | O-GLYCOPROTEIN-2-ACETAMIDO-2-DEOXY-3-D-GLYCOPYRANOSIDASE INHIBITORS | |
FR3056393B1 (en) | ORTHESIS OF EXTENSION OF JAWS | |
MA43361A (en) | COMPOSITION FOR THE CARE AND PROTECTION OF CROPS | |
DK3595667T3 (en) | PHARMACEUTICAL COMPOSITIONS COMPRISING A JAK INHIBITOR | |
MA47203A (en) | NHE-MEDIATION ANTIPORT INHIBITORS | |
DK3403674T3 (en) | PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF PAIN | |
MA43806A (en) | SPRAY COATED FERTILIZER COMPOSITION | |
MA47495A (en) | ANTI-INFLAMMATORY COMPOSITIONS INCLUDING IRAQ AND JAK INHIBITORS | |
IL276352A (en) | Quinoline compounds as irak inhibitors and uses thereof | |
IL279877A (en) | Ivosidenib forms and pharmaceutical compositions | |
IT201900020514A1 (en) | IRRIGATION AND / OR FERTIGATION DEVICE | |
IT201900004805A1 (en) | ANTIPPIRANT AND DEODORANT COMPOSITIONS | |
DK3601450T3 (en) | COATING COMPOSITION AND USE THEREOF | |
GB201807576D0 (en) | Compositions and uses thereof | |
GB201812334D0 (en) | Compositions and uses thereof | |
MA55203A (en) | AZETIDINYL 0-GLYC0PR0TEIN-2-ACETAMID0-2-DESOXY-3-D-GLUC0PYRAN0SIDASE INHIBITORS | |
MA46666A (en) | COMPOSITIONS OF HERBS FOR TOPICAL USE | |
IT201700058066A1 (en) | COMPOSITION OF ANTI-INFLAMMATORY AND ANALGESIC ACTIVITIES |